Tandem enters Italy through partnership with Humanitas as AI becomes foundational to European clinical workflows

Tandem Health is entering Italy through a partnership with Humanitas, one of the country's leading healthcare groups, as AI moves from isolated pilots into everyday clinical practice across Europe.

The partnership marks Tandem's entry into one of Europe's largest healthcare systems — and reflects a broader pattern that is now visible across the continent: leading providers are no longer evaluating AI for documentation.
They are deploying it.

AI is moving into the clinical core

Across European healthcare, the question has shifted. Early adoption was shaped by curiosity and proof-of-concept pilots. Decision-making today centres on workflow integration, regulatory compliance, and measurable impact on clinician workload.

Humanitas is one of Italy's most recognised clinical institutions, combining a network of 12 hospitals and 25 medical centres with a globally respected research institute and university. Recognised by the Ministry of Health as an IRCCS and ranked as the best hospital in Italy by Agenas, Humanitas was among the first Italian hospitals to establish an AI centre fully integrated with clinical and research activity — a space where physicians, data scientists, and engineers collaborate directly on diagnostic and treatment pathways.

That institutional profile makes this partnership a signal, not just a commercial milestone. When organisations at this level move, others follow.

What Tandem brings to Italian clinical practice

Tandem is building the AI-native operating system for clinics — enabling healthcare organisations to reduce documentation workload and integrate AI directly into existing clinical workflows, without requiring clinicians to change how they work.

Tandem is already used by more than 5,000 healthcare organisations across Europe, including large-scale deployments with the NHS and leading private care providers. It integrates with over 100 electronic health record systems and is live in more than 10 European markets. Its Coding Assistant holds MDR Class IIa certification — the first in Europe in its category to reach this classification.

The approach in Italy follows the same pattern established in other markets: partner with a flagship institution, embed directly into existing clinical workflows, and let adoption spread from there.

In their own words

"Across Europe, healthcare is moving from experimenting with AI to running on it. We work with the most forward-looking providers, integrate into what they already use, and move straight into real clinical practice. From there, adoption spreads. Entering Italy with Humanitas is part of that shift." — Lukas Didon, Director of Global Expansion, Tandem Health

"This collaboration is part of our innovation strategy to bring practical solutions into clinical workflows, reducing administrative burden and enabling clinicians to focus more on patient care — and create the conditions for high-quality care that is increasingly scalable and sustainable." — Luciano Ravera, CEO, Humanitas Group

"Technological innovation in healthcare is no longer only about adopting new tools. It is about building infrastructure that makes clinical work more sustainable, more efficient, and more patient-centred." — Viktor Savevski, Chief Innovation Officer, Humanitas Group

What this signals for Europe

Italy is one of the last major European healthcare markets not yet in Tandem's footprint. Its entry — through a partnership with an institution of Humanitas's standing — reflects the pace at which clinical AI is now moving from the periphery of healthcare operations to its core.

Tandem is continuing its expansion across Europe's remaining markets through 2026, working with leading healthcare organisations to embed AI directly into clinical practice.